The Hope Foundation is honored to provide fellowships and grants, educational programs, group meeting support, and professional development for SWOG‘s network of cancer clinicians, nurses, CRAs, scientists, and patient advocates.
These funding opportunities are made possible by our generous donors, including individuals like you.
Research Support
SWOG/Hope Impact Award Program
The SWOG/Hope Impact Award is a funding program that encourages novel and innovative SWOG research by supporting the early and conceptual stages of these projects.
Secondary Data Analysis
Secondary Data Analysis Projects strive to connect SWOG researchers with the statistical support required to conduct database analyses using SWOG clinical trials data alone or in combination with registry or claims data, or other potential linkages.
SWOG Early Exploration and Development (SEED) Fund
Awards are made from The Hope Foundation for Cancer Research SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN).
SWOG Trial Support (STrS)
STrS awards are provided to support components of approved and activated studies that require additional funding during patient enrollment.
Trial-Specific Education Funds
A program offered to support the provision of education and training for sites participating in complex SWOG trials. Studies that are deemed to have non-standard endpoints, complicated design, and/or registration potential are eligible for up to $5,000.
NCORP Pilot Grant Program
Improving Participation Of Diverse Populations In Clinical Trials. Awards are made from the NCORP Pilot Grant Program to foster improved representation of under-resourced populations in cancer clinical trial accrual. Grants from the program are issued through a competitive, peer-reviewed process, and projects are funded for up to $50,000 (direct costs).
Career Development
Dr. Charles A. Coltman Jr. Fellowship
The primary purpose of the Dr. Charles A. Coltman Jr. Fellowship is to engage outstanding early-career investigators from SWOG-affiliated institutions in learning clinical trial methodology within an academic and network group environment that will lead to independent clinical research.
John Crowley, PhD Award
This one-week residency encourages statistical excellence in clinical trials, providing a unique opportunity to interact and collaborate with statistical faculty and data management staff at a leading publicly funded, national multi-center clinical trials organization.
Virtual Grant Writing Workshop
This virtual grant-writing workshop is designed for early stage investigators preparing for future grant submissions, including career development awards (i.e., K awards, K equivalents) and pilot/research grants (i.e., R03, R21, etc.).
Early Stage Investigator Training Course
The Early Stage Investigator Training Course is three full days of protocol development, trial management, and statistical analysis – topics identified by seasoned and new researchers alike as areas of specific concern to those entering the field.
Advanced Practice PRoviders Mentorship Program (MAPP)
A mentoring intervention for advanced practice providers (APPs) across the National Clinical Trials Network: The NCTN MAPP Program.
Community Support
Committee Meeting Funds
SWOG disease, research, and administrative committee chairs are provided the opportunity to request up to $15,000 annually to support committee efforts at meetings not currently funded by the NCTN or NCORP grants.
CRA/Nurse Travel Support Program
Funding available for CRAs/nurses to travel to SWOG group meetings annually.
Vogelzang GU Scholars Program
Established in honor of the late SWOG leader, mentor, and friend Dr. Nicholas J. Vogelzang. Pairs GU investigators with a senior mentor and supports travel to SWOG group meetings.
The Sunshine Act
The Physician Payments Sunshine Act passed as part of the Patient Protection and Affordable Care Act in 2010. The law is designed to bring transparency to financial relationships between physicians, teaching hospitals, and the pharmaceutical industry. This is pertinent to The Hope Foundation because we receive donations from manufacturers who are required to pass reporting obligations on to the third party charitable organizations that they support.
The Hope Foundation is not required to make any direct reports to the government as a result of The Sunshine Act. However, The Foundation is required to report to certain funders who support our programs. These funders are manufacturers bound by the reporting regulations, whose charitable donations to the Foundation may support travel, meals or research for grantees who are US licensed physicians. With the Sunshine Act, payments or transfers of value made to physicians indirectly through a charitable organization must be reported if the manufacturer knows that money will be paid to physicians or earmarks money to go to physicians. At Hope, this is the scenario for many of our restricted donations.
